About
Monoclonal Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBoston & New England
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
9
As Collaborator
0
Total Enrollment
504
By Phase
PHASE3: 2PHASE1: 2PHASE2: 4PHASE1/PHASE2: 1
By Status
RECRUITING: 2COMPLETED: 2UNKNOWN: 2ENROLLING_BY_INVITATION: 1ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT07204938Lead Sponsor
A Long-Term Study of Navenibart in Participants With Hereditary Angioedema
PHASE3Enrolling by invitation
145 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2031
NCT06842823Lead Sponsor
A Study of Navenibart in Participants With Hereditary Angioedema
PHASE3Recruiting
145 participants
Started: Mar 20, 2025 · Completed: Sep 30, 2027
NCT06782477Lead Sponsor
A Study of STAR-0310 in Healthy Adult Participants
PHASE1Recruiting
40 participants
Started: Jan 31, 2025 · Completed: Jan 31, 2026
NCT06007677Lead Sponsor
A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema
PHASE2Active, not recruiting
56 participants
Started: Sep 26, 2023 · Completed: Mar 31, 2031
NCT05695248Lead Sponsor
A Study of STAR-0215 in Participants With Hereditary Angioedema
PHASE1/PHASE2Completed
29 participants
Started: Feb 21, 2023 · Completed: Mar 13, 2025
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...